(Q71806069)

English

Effect of low-dose simvastatin on cholesterol levels, oxidative susceptibility, and antioxidant levels of low-density lipoproteins in patients with hypercholesterolemia: a pilot study

scientific article published on 01 May 1995

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7585842%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Effect of low-dose simvastatin on cholesterol levels, oxidative susceptibility, and antioxidant levels of low-density lipoproteins in patients with hypercholesterolemia: a pilot study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7585842%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference

based on heuristic

inferred from title

author name string

H. Yoshida

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7585842

25 May 2024

T. Ishikawa

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7585842

25 May 2024

M. Ayaori

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7585842

25 May 2024

H. Shige

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7585842

25 May 2024

H. Hosoai

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7585842

25 May 2024

E. Nishio

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7585842

25 May 2024

K. Tomiyasu

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7585842

25 May 2024

T. Yamashita

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7585842

25 May 2024

M. Suzukawa

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7585842

25 May 2024

M. Nishiwaki

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7585842

25 May 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7585842

25 May 2024

publication date

1 May 1995

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7585842%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

full work available at URL

https://api.elsevier.com/content/article/PII:0149291895801030?httpAccept=text/xml

1 reference

10.1016/0149-2918(95)80103-0

https://api.crossref.org/works/10.1016/0149-2918(95)80103-0

25 May 2024

https://api.elsevier.com/content/article/PII:0149291895801030?httpAccept=text/plain

1 reference

10.1016/0149-2918(95)80103-0

https://api.crossref.org/works/10.1016/0149-2918(95)80103-0

25 May 2024

Clinical Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7585842%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7585842%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7585842%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

379-389

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7585842%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Role of oxidized low density lipoprotein in atherogenesis

2

1 reference

10.1016/0149-2918(95)80103-0

https://api.crossref.org/works/10.1016/0149-2918(95)80103-0

25 May 2024

Lovastatin inhibits low-density lipoprotein oxidation and alters its fluidity and uptake by macrophages: in vitro and in vivo studies

3

1 reference

10.1016/0149-2918(95)80103-0

https://api.crossref.org/works/10.1016/0149-2918(95)80103-0

25 May 2024

Simvastatin inhibits the oxidation of low-density lipoproteins by activated human monocyte-derived macrophages

4

1 reference

10.1016/0149-2918(95)80103-0

https://api.crossref.org/works/10.1016/0149-2918(95)80103-0

25 May 2024

The role of vitamin E and carotenoids in preventing oxidation of low density lipoproteins

5

1 reference

10.1016/0149-2918(95)80103-0

https://api.crossref.org/works/10.1016/0149-2918(95)80103-0

25 May 2024

Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does alpha-tocopherol

6

1 reference

10.1016/0149-2918(95)80103-0

https://api.crossref.org/works/10.1016/0149-2918(95)80103-0

25 May 2024

Hydroxymethylglutaryl coenzyme A reductase inhibitors as monotherapy in the treatment of hypercholesterolemia

7

1 reference

10.1016/0149-2918(95)80103-0

https://api.crossref.org/works/10.1016/0149-2918(95)80103-0

25 May 2024

Efficacy and tolerability of simvastatin and pravastatin in patients with primary hypercholesterolemia (multicountry comparative study). The European Study Group

8

1 reference

10.1016/0149-2918(95)80103-0

https://api.crossref.org/works/10.1016/0149-2918(95)80103-0

25 May 2024

THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM

10

1 reference

10.1016/0149-2918(95)80103-0

https://api.crossref.org/works/10.1016/0149-2918(95)80103-0

25 May 2024

Effect of gemfibrozil on composition of lipoproteins and distribution of LDL subspecies

11

1 reference

10.1016/0149-2918(95)80103-0

https://api.crossref.org/works/10.1016/0149-2918(95)80103-0

25 May 2024

Effects of Ca-Antagonists on Oxidative Susceptibility of Low Density Lipoprotein (LDL)

13

1 reference

10.1016/0149-2918(95)80103-0

https://api.crossref.org/works/10.1016/0149-2918(95)80103-0

25 May 2024

Protein measurement with the Folin phenol reagent

14

1 reference

10.1016/0149-2918(95)80103-0

https://api.crossref.org/works/10.1016/0149-2918(95)80103-0

25 May 2024

Simultaneous determination of tocopherols, ubiquinols, and ubiquinones in blood, plasma, tissue homogenates, and subcellular fractions.

15

1 reference

10.1016/0149-2918(95)80103-0

https://api.crossref.org/works/10.1016/0149-2918(95)80103-0

25 May 2024

Low density lipoprotein composition and oxidizability in coronary disease--apparent favourable effect of beta blockers

16

1 reference

10.1016/0149-2918(95)80103-0

https://api.crossref.org/works/10.1016/0149-2918(95)80103-0

25 May 2024

A simple method for the isolation and purification of total lipides from animal tissues

17

1 reference

10.1016/0149-2918(95)80103-0

https://api.crossref.org/works/10.1016/0149-2918(95)80103-0

25 May 2024

Effects of gammalinolenic acid on plasma lipoproteins and apolipoproteins

18

1 reference

10.1016/0149-2918(95)80103-0

https://api.crossref.org/works/10.1016/0149-2918(95)80103-0

25 May 2024

Continuous monitoring of in vitro oxidation of human low density lipoprotein

20

1 reference

10.1016/0149-2918(95)80103-0

https://api.crossref.org/works/10.1016/0149-2918(95)80103-0

25 May 2024

Effects of alcohol consumption on antioxidant content and susceptibility of low-density lipoprotein to oxidative modification

21

1 reference

10.1016/0149-2918(95)80103-0

https://api.crossref.org/works/10.1016/0149-2918(95)80103-0

25 May 2024

Effect of dietary antioxidant combinations in humans. Protection of LDL by vitamin E but not by beta-carotene.

23

1 reference

10.1016/0149-2918(95)80103-0

https://api.crossref.org/works/10.1016/0149-2918(95)80103-0

25 May 2024

Antioxidant vitamins and low-density-lipoprotein oxidation

24

1 reference

10.1016/0149-2918(95)80103-0

https://api.crossref.org/works/10.1016/0149-2918(95)80103-0

25 May 2024

Lovastatin decreases coenzyme Q levels in rats

25

1 reference

10.1016/0149-2918(95)80103-0

https://api.crossref.org/works/10.1016/0149-2918(95)80103-0

25 May 2024

Lovastatin decreases coenzyme Q levels in humans

26

1 reference

10.1016/0149-2918(95)80103-0

https://api.crossref.org/works/10.1016/0149-2918(95)80103-0

25 May 2024

Tissue selectivity of the cholesterol-lowering agents lovastatin, simvastatin and pravastatin in rats in vivo

27

1 reference

10.1016/0149-2918(95)80103-0

https://api.crossref.org/works/10.1016/0149-2918(95)80103-0

25 May 2024

Effects of diets rich in monounsaturated fatty acids on plasma lipoproteins--the Jerusalem Nutrition Study: high MUFAs vs high PUFAs

29

1 reference

10.1016/0149-2918(95)80103-0

https://api.crossref.org/works/10.1016/0149-2918(95)80103-0

25 May 2024

Effects of oleate-rich and linoleate-rich diets on the susceptibility of low density lipoprotein to oxidative modification in mildly hypercholesterolemic subjects

30

1 reference

10.1016/0149-2918(95)80103-0

https://api.crossref.org/works/10.1016/0149-2918(95)80103-0

25 May 2024

Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man

31

1 reference

10.1016/0149-2918(95)80103-0

https://api.crossref.org/works/10.1016/0149-2918(95)80103-0

25 May 2024

Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects

32

1 reference

10.1016/0149-2918(95)80103-0

https://api.crossref.org/works/10.1016/0149-2918(95)80103-0

25 May 2024

Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size

33

1 reference

10.1016/0149-2918(95)80103-0

https://api.crossref.org/works/10.1016/0149-2918(95)80103-0

25 May 2024

Low density lipoprotein particle size and coronary artery disease

35

1 reference

10.1016/0149-2918(95)80103-0

https://api.crossref.org/works/10.1016/0149-2918(95)80103-0

25 May 2024

LDL particle size distribution. Results from the Framingham Offspring Study

36

1 reference

10.1016/0149-2918(95)80103-0

https://api.crossref.org/works/10.1016/0149-2918(95)80103-0

25 May 2024

Effect of gender, age, and lipid status on low density lipoprotein subfraction distribution. Results from the Framingham Offspring Study

37

1 reference

10.1016/0149-2918(95)80103-0

https://api.crossref.org/works/10.1016/0149-2918(95)80103-0

25 May 2024

Low density lipoprotein subfractions and relationship to other risk factors for coronary artery disease in healthy individuals

38

1 reference

10.1016/0149-2918(95)80103-0

https://api.crossref.org/works/10.1016/0149-2918(95)80103-0

25 May 2024

Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall study

39

1 reference

10.1016/0149-2918(95)80103-0

https://api.crossref.org/works/10.1016/0149-2918(95)80103-0

25 May 2024

Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population.

40

1 reference

10.1016/0149-2918(95)80103-0

https://api.crossref.org/works/10.1016/0149-2918(95)80103-0

25 May 2024

Effect of pravastatin treatment on glucose, insulin, and lipoprotein metabolism in patients with hypercholesterolemia.

41

1 reference

10.1016/0149-2918(95)80103-0

https://api.crossref.org/works/10.1016/0149-2918(95)80103-0

25 May 2024

Identifiers

10.1016/0149-2918(95)80103-0

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7585842%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7585842%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q71806069&oldid=2166459622"